Per Sandström

Medical Director, R&D TA Urology ar Ferring Pharmaceuticals. Clinical Oncologist with GU Cancer focus.

[Per Sandström @persandstorm]

@DrRanaMcKay @UCSDCancer Congratulations Rana!

[Per Sandström @persandstorm]

There is value in knowing your target when using targeted therapy! Nice work 👍

[Niklas Klümper @niklas_kluemper]

NECTIN4 amplification predicts response to Enfortumab vedotin in mUC! It occurs frequently across solid tumors (app. 25% of mUC)➡️potential tumor-agnostic biomarker for NECTIN4-targeting therapies! Happy to share our poster K17 @ASCO #GU24! @Markuseckstein3 @OncoAlert @urotoday

[Per Sandström @persandstorm]

The question whether to treat the primary is likely not just a volume game! Read this thread by Alex Wyatt

[Alex Wyatt @ResearchWyatt]

Our latest study with @piet_ost, of whole prostates, lymph nodes, and ctDNA at initial diagnosis in de novo metastatic prostate cancer (distant mets) is out in @NatureCancer: https://t.co/6iMFs899iX. 1/n thread 👇

[Praful Ravi @PrafulRavi1]

MFS surrogacy for OS in the ‘contemporary’ era - work from #ICECAP confirms validity of MFS as a surrogate endpt for OS in era of greater access to docetaxel and ARPIs for metastatic disease, published in @Annals_Oncology
https://t.co/P8djwoX5Wt

[Per Sandström @persandstorm]

@segerfeldt Nja, vi måste ju ner mycket och tiden är begränsad

[Per Sandström @persandstorm]

@thorneby Regionerna- har blivit ett försäkringsbolag med en ny affärsidé, vi ersätter allt till alla utom de som verkligen behöver!
Ofattbart att detta får fortsätta, ersättningen för en förkylning borde vara nära noll och registreras något som ger högre ersättning borde man diskas

[Per Sandström @persandstorm]

@thorneby Regionen erbjuder- vård på dina villkor! Alla andra betalar!

[Yüksel Ürün @DrYukselUrun]

🇸🇪🔬 Recent Swedish study reveals a game-changer! From 2008 to 2020, advanced prostate cancer treatments have led to a notable increase in survival rates. 📈
@JAMANetworkOpen @OncoAlert @PCFnews @myESMO @ASCO @Uroweb @APCCC_Lugano @ChrisSweens1 #ProstateCancer
doi:10.1001/jamanetworkopen.2023.36604

[Yüksel Ürün @DrYukselUrun]

🔬 The mystery of cancer spread! With a massive database of 25,000+ metastatic patients, researchers uncover the genomic secrets behind metastasis in 50 tumor types.
🧬🧬Chromosomal instability plays a pivotal, yet complex role. Dive into the groundbreaking findings! 🧬 #CancerResearch
@DSolit @DrRosenbergMSK @YJanjigianMD @DrDarrenFeldman @MSKCancerCenter @motzermd @morr316 @OncoAlert @CellCellPress
DOI:https://t.co/Ch6BXlTkR1 (open access)

[Per Sandström @persandstorm]

@Sevans_axelsson Incredible work Susan!

[Frederik Persson @FrederikPersson]

#CKD is prevalent in primary care as our analysis from @CopLab_ucph demonstrates. An opportunity for screening and early intervention? At least worth a discussion and future studies. @RikkeBorg
@Stenodiabetes @kamleshkhunti @P_Rossing https://t.co/3mIMu76jMZ

[Per Sandström @persandstorm]

RadiCAL!

[Toni Choueiri, MD @DrChoueiri]

After CONTACT-3, cabozantinib single agent in metastatic RCC post-PD1 remains a standard, so we urge the #GU community to enroll on @ALLIANCE_org #RadiCAL with Chair @DrRanaMcKay :

-Metastatic RCC (clear/non-clear cell)
-Prior systemic agents
-BONE mets

Patients will be randomized to cabozantinib + radium-223 dichloride or cabozantinib alone

FIND A SITE NEAR YOU!!!!

https://t.co/irDLNwXsuQ

[Per Sandström @persandstorm]

@EAntonarakis @CathyHandy Interesting finding!

[Per Sandström @persandstorm]

@ChrisSweens1 @piet_ost @Prof_IanD @CalaisJeremie @JuddMoul @felixfengmd @KennethPienta Agree but would ad that a + BS also indicates an additional driver of the disease in the bone micro environment, besides the androgen signaling pathway.

[Per Sandström @persandstorm]

@MariaBjrk2 @fnyosv Bor i Spånga, landstingsdriven vårdcentral, fast läkare senast jag var där med dottern.

[Per Sandström @persandstorm]

@lisa_pelling Sitter på ett tåg/Metro utan både förare och värd, måste vara riskabelt..

[Per Sandström @persandstorm]

@andreasroder1 @UrologicalRunit @THelgstrand @torbennielsen__ @karinaklovgaard @signebenzon Congrats, well done!

[Per Sandström @persandstorm]

@Dr_K_Rahbar Congratulations Kambiz! This study makes a lot of sense, thanks to you and the team for pursuing this. A bit surprised by the similar HRs for the different compartments, is it an effect of the different magnitude of the volumes ?

[Mark C. Markowski @MarkowskiGUOnc]

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer https://t.co/dTAFS8ZZla

[Per Sandström @persandstorm]

@OncoAlert @weoncologists Welcome back 🎆